Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 2 | $378,053 |
Sells | 24 | $3,098,385 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Feb 2024 18:11 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 05 Feb 2024 | Sale | 36,248 | 2.2209 | 80,503 | D |
22 Nov 2023 17:09 | VRNA | Verona Pharma plc | EDWARDS MARTIN | Director | 20 Nov 2023 | Purchase | 33,736 | 1.837 | 61,973 | D |
08 Nov 2023 16:15 | VRNA | Verona Pharma plc | EBSWORTH DAVID R | Director | 06 Nov 2023 | Purchase | 160,000 | 1.9755 | 316,080 | D |
03 Nov 2023 20:11 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 Nov 2023 | Sale | 58,752 | 1.92 | 112,804 | D |
03 May 2024 19:21 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 May 2024 | Sale | 36,248 | 1.9596 | 71,032 | D |
07 Aug 2023 21:15 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 07 Aug 2023 | Sale | 1,512 | 2.4679 | 3,731 | D |
07 Aug 2023 21:15 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 04 Aug 2023 | Sale | 26,352 | 2.4992 | 65,859 | D |
07 Aug 2023 21:15 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 03 Aug 2023 | Sale | 20,608 | 2.539 | 52,324 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 07 Aug 2023 | Sale | 8,616 | 2.4679 | 21,263 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 04 Aug 2023 | Sale | 150,000 | 2.4992 | 374,880 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 03 Aug 2023 | Sale | 117,272 | 2.539 | 297,754 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 07 Aug 2023 | Sale | 8,616 | 2.4679 | 21,263 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 04 Aug 2023 | Sale | 150,000 | 2.4992 | 374,880 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 03 Aug 2023 | Sale | 117,272 | 2.539 | 297,754 | D |
07 Aug 2023 21:19 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 07 Aug 2023 | Sale | 1,600 | 2.4679 | 3,949 | D |
07 Aug 2023 21:19 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 04 Aug 2023 | Sale | 27,944 | 2.4992 | 69,838 | D |
07 Aug 2023 21:19 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 Aug 2023 | Sale | 21,848 | 2.539 | 55,472 | D |
07 Aug 2023 21:19 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 Aug 2023 | Sale | 28,752 | 2.55 | 73,318 | D |
03 Aug 2023 20:30 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 02 Aug 2023 | Sale | 12,944 | 2.593 | 33,564 | D |
03 Aug 2023 20:30 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 01 Aug 2023 | Sale | 18,608 | 2.679 | 49,851 | D |
03 Aug 2023 20:31 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 01 Aug 2023 | Sale | 105,944 | 2.679 | 283,824 | D |
03 Aug 2023 20:31 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 02 Aug 2023 | Sale | 73,704 | 2.593 | 191,114 | D |
03 Aug 2023 20:27 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 02 Aug 2023 | Sale | 13,728 | 2.593 | 35,597 | D |
03 Aug 2023 20:27 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 01 Aug 2023 | Sale | 19,736 | 2.679 | 52,873 | D |
03 Aug 2023 20:29 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 02 Aug 2023 | Sale | 73,704 | 2.593 | 191,114 | D |
03 Aug 2023 20:29 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 01 Aug 2023 | Sale | 105,944 | 2.679 | 283,824 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)